ArticleBMC infectious diseases2026
Consensus-based computational mapping of NS1 antigenic determinants in dengue and Zika viruses to improve diagnostic specificity.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Computational methods in physical virology: a critical perspective across lengths and timescales.FEMS microbiology reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCross-reactivity between samples from phylogenetically related organisms remains a significant challenge in antigen detection by lateral flow assays. Recent advancements in bioinformatics tools have significantly enhanced our understanding of the complex interactions between antigenic proteins and antibodies, paving the way for the development of more precise and effective solutions to address these challenges.
methodsIn this study, we used two common modeling tools, SWISS-MODEL and AlphaFold (2 and 3), to construct three-dimensional (3D) models of the nonstructural 1 (NS1) protein from dengue (DENV) and Zika viruses (ZIKV) based on their protein sequences. Both linear and 3D structures of the proteins were used to predict antigenicity (Jameson-Wolf and Kolaskar-Tongaonkar methods) and B-cell epitopes (Bepipred-2.0, ElliPro, SEPPA3, and DiscoTope methods), and the results obtained from the two modeling tools were compared. Furthermore, molecular simulations were conducted utilizing FORTE and PROCEEDpKa to estimate binding affinities and predict electrostatic epitopes, respectively.
resultsOur consensus-based pipeline consistently identified two primary antigenic hotspots: 107-127 and 301-319. The antigenicity of the 107-127 region was strongly corroborated by its overlap with the crystallographic binding sites of known antibodies (22NS1, 2B7, and 1G5.3), validating our approach. The 301-319 region emerged as a novel, high-confidence candidate epitope. Furthermore, electrostatic and affinity analyses revealed distinct interaction profiles, providing a molecular basis for discriminating between serotype-specific and cross-reactive antibody responses.
conclusionsOur computational pipeline identified key NS1 antigenic determinants, validating the 107-127 region and revealing region 301-319 as a novel epitope candidate. These findings provide specific targets for diagnostics designed to circumvent flavivirus cross-reactivity. The validated workflow itself serves as a robust, adaptable framework for rapid antigen prediction, accelerating the development of targeted diagnostics and immunotherapies for future emerging viruses. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.